(NASDAQ: PEPG) Pepgen's forecast annual earnings growth rate of N/A is not forecast to beat the US Biotechnology industry's average forecast earnings growth rate of 45.68%, and while it is not forecast to beat the US market's average forecast earnings growth rate of 42.81%.
Pepgen's earnings in 2025 is -$93,557,000.On average, 8 Wall Street analysts forecast PEPG's earnings for 2025 to be -$168,577,520, with the lowest PEPG earnings forecast at -$206,835,907, and the highest PEPG earnings forecast at -$116,218,873. On average, 8 Wall Street analysts forecast PEPG's earnings for 2026 to be -$116,404,493, with the lowest PEPG earnings forecast at -$177,191,673, and the highest PEPG earnings forecast at -$51,973,657.
In 2027, PEPG is forecast to generate -$119,738,782 in earnings, with the lowest earnings forecast at -$179,212,870 and the highest earnings forecast at -$46,198,807.